Human studies have shown that the serum levels of Apelin-13, Apelin-36, and NO are higher in patients with GDM than in healthy mothers in the second trimester of pregnancy, who suffer from glucose and lipid metabolism disorders (85). The gene discussed is APLN; the disease is Disorder of lipid metabolism.